Nonviral delivery of genetic medicine for therapeutic angiogenesis

Hyun Ji Park, Fan Yang, Seung Woo Cho

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Genetic medicines that induce angiogenesis represent a promising strategy for the treatment of ischemic diseases. Many types of nonviral delivery systems have been tested as therapeutic angiogenesis agents. However, their delivery efficiency, and consequently therapeutic efficacy, remains to be further improved, as few of these technologies are being used in clinical applications. This article reviews the diverse nonviral gene delivery approaches that have been applied to the field of therapeutic angiogenesis, including plasmids, cationic polymers/lipids, scaffolds, and stem cells. This article also reviews clinical trials employing nonviral gene therapy and discusses the limitations of current technologies. Finally, this article proposes a future strategy to efficiently develop delivery vehicles that might be feasible for clinically relevant nonviral gene therapy, such as high-throughput screening of combinatorial libraries of biomaterials.

Original languageEnglish
Pages (from-to)40-52
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume64
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Medicine
Genetic Therapy
Technology
Biocompatible Materials
Therapeutics
Polymers
Plasmids
Stem Cells
Clinical Trials
Lipids
Genes

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{02d41bc2cf3a4a5a93e8a08f4ca5a33a,
title = "Nonviral delivery of genetic medicine for therapeutic angiogenesis",
abstract = "Genetic medicines that induce angiogenesis represent a promising strategy for the treatment of ischemic diseases. Many types of nonviral delivery systems have been tested as therapeutic angiogenesis agents. However, their delivery efficiency, and consequently therapeutic efficacy, remains to be further improved, as few of these technologies are being used in clinical applications. This article reviews the diverse nonviral gene delivery approaches that have been applied to the field of therapeutic angiogenesis, including plasmids, cationic polymers/lipids, scaffolds, and stem cells. This article also reviews clinical trials employing nonviral gene therapy and discusses the limitations of current technologies. Finally, this article proposes a future strategy to efficiently develop delivery vehicles that might be feasible for clinically relevant nonviral gene therapy, such as high-throughput screening of combinatorial libraries of biomaterials.",
author = "Park, {Hyun Ji} and Fan Yang and Cho, {Seung Woo}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.addr.2011.09.005",
language = "English",
volume = "64",
pages = "40--52",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "1",

}

Nonviral delivery of genetic medicine for therapeutic angiogenesis. / Park, Hyun Ji; Yang, Fan; Cho, Seung Woo.

In: Advanced Drug Delivery Reviews, Vol. 64, No. 1, 01.01.2012, p. 40-52.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Nonviral delivery of genetic medicine for therapeutic angiogenesis

AU - Park, Hyun Ji

AU - Yang, Fan

AU - Cho, Seung Woo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Genetic medicines that induce angiogenesis represent a promising strategy for the treatment of ischemic diseases. Many types of nonviral delivery systems have been tested as therapeutic angiogenesis agents. However, their delivery efficiency, and consequently therapeutic efficacy, remains to be further improved, as few of these technologies are being used in clinical applications. This article reviews the diverse nonviral gene delivery approaches that have been applied to the field of therapeutic angiogenesis, including plasmids, cationic polymers/lipids, scaffolds, and stem cells. This article also reviews clinical trials employing nonviral gene therapy and discusses the limitations of current technologies. Finally, this article proposes a future strategy to efficiently develop delivery vehicles that might be feasible for clinically relevant nonviral gene therapy, such as high-throughput screening of combinatorial libraries of biomaterials.

AB - Genetic medicines that induce angiogenesis represent a promising strategy for the treatment of ischemic diseases. Many types of nonviral delivery systems have been tested as therapeutic angiogenesis agents. However, their delivery efficiency, and consequently therapeutic efficacy, remains to be further improved, as few of these technologies are being used in clinical applications. This article reviews the diverse nonviral gene delivery approaches that have been applied to the field of therapeutic angiogenesis, including plasmids, cationic polymers/lipids, scaffolds, and stem cells. This article also reviews clinical trials employing nonviral gene therapy and discusses the limitations of current technologies. Finally, this article proposes a future strategy to efficiently develop delivery vehicles that might be feasible for clinically relevant nonviral gene therapy, such as high-throughput screening of combinatorial libraries of biomaterials.

UR - http://www.scopus.com/inward/record.url?scp=84858442652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858442652&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2011.09.005

DO - 10.1016/j.addr.2011.09.005

M3 - Review article

C2 - 21971337

AN - SCOPUS:84858442652

VL - 64

SP - 40

EP - 52

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 1

ER -